CHENGDU, China, Dec. 4, 2023 /PRNewswire/ — Technoderma Medicines, Inc. (“the Company”), a clinical stage biopharmaceutical company, is pleased to report that the Company has completed a Phase 1 clinical trial (NCT05525468) of TDM-180935 topical ointment for Atopic Dermatitis (AD). This first clinical trial in the AD program included single dose and multidose escalation cohorts… Continue reading Technoderma Medicines Completes Phase 1 Dose Escalation Clinical Trial of TDM-180935 for Atopic Dermatitis
Category: Newswire
NASA, Partners Launch US Greenhouse Gas Center to Share Climate Data
WASHINGTON, Dec. 4, 2023 /PRNewswire/ — NASA Administrator Bill Nelson, U.S. Environmental Protection Agency (EPA) Administrator Michael Regan, and other United States government leaders unveiled the U.S. Greenhouse Gas Center Monday during the 28th annual United Nations Climate Conference (COP28). Continue Reading Visualization of total carbon dioxide in the Earth’s atmosphere in 2021 (Credit NASA). “NASA… Continue reading NASA, Partners Launch US Greenhouse Gas Center to Share Climate Data
Treydora Transforms Military Training with Cutting-Edge VR Applications
NEW YORK, Dec. 4, 2023 /PRNewswire/ — Treydora, the groundbreaking production company at the forefront of AI and VR technology, is ushering in a new era of military training with its innovative VR platform. Delivering profoundly enhanced statistical analysis, combat training exercises, and mock-ups, Treydora is revolutionizing how armed forces prepare for the challenges of… Continue reading Treydora Transforms Military Training with Cutting-Edge VR Applications
Ease Learning and Freedom Learning Group Announce Merger, Position for Growth
Trailblazers in skills-based learning combine operations to enhance capabilities while supporting the employment and upskilling of military spouses and veterans BOSTON, Dec. 4, 2023 /PRNewswire/ — Freedom Learning Group and Ease Learning have announced the strategic merger of the two e-learning brands. This merger will combine two strong companies devoted to designing high-quality learning experiences and empowering… Continue reading Ease Learning and Freedom Learning Group Announce Merger, Position for Growth
Azul is included in B3’s Corporate Sustainability Index (ISE B3) for Third Consecutive Year
Being part of the index reinforces Azul’s commitment to improve and develop environmental, social, and governance aspects, generating sustainable results for all stakeholders SÃO PAULO, Dec. 4, 2023 /PRNewswire/ — Azul S.A., “Azul”, (B3: AZUL4, NYSE: AZUL), the largest airline in Brazil by number of flights and cities served, informs that it has been once more included in the Corporate… Continue reading Azul is included in B3’s Corporate Sustainability Index (ISE B3) for Third Consecutive Year
Unlock Health Introduces ROI Insights Tool to Improve Healthcare Marketing Effectiveness
Unlock ROI Insights™ is the only purpose-built solution available for healthcare marketers to connect the dots between campaign and clinical data in a way that demonstrates attributable downstream impact. NASHVILLE, Tenn., Dec. 4, 2023 /PRNewswire/ — Today, Unlock Health™, a healthcare technology and -services growth platform, announced the commercial availability of Unlock ROI Insights™, the first-ever full-funnel measurement… Continue reading Unlock Health Introduces ROI Insights Tool to Improve Healthcare Marketing Effectiveness
Abbisko Therapeutics Announced the Entry into a Licensing Agreement for Pimicotinib (ABSK021) with Merck
SHANGHAI, Dec. 4, 2023 /PRNewswire/ — On 4 Dec. 2023, Abbisko Therapeutics announced that it has entered into a licensing agreement with Merck, a leading science and technology company headquartered in Darmstadt, Germany. Under the terms of the agreement, Merck will be granted an exclusive license to commercialize products comprising or containing pimicotinib (ABSK021) for… Continue reading Abbisko Therapeutics Announced the Entry into a Licensing Agreement for Pimicotinib (ABSK021) with Merck
Sara Nayeem, M.D., Experienced Biopharmaceutical Venture Investor, Joins Enavate Sciences as Executive Vice President, Investments
MENLO PARK, Calif., Dec. 4, 2023 /PRNewswire/ — Enavate Sciences, a portfolio company of Patient Square Capital, is pleased to announce that Sara M. Nayeem, M.D. has joined the firm as Executive Vice President, Investments. Dr. Nayeem reports to James Boylan, Chief Executive Officer of Enavate Sciences, and will serve an integral role in the… Continue reading Sara Nayeem, M.D., Experienced Biopharmaceutical Venture Investor, Joins Enavate Sciences as Executive Vice President, Investments
Las cinco mejores predicciones de ciberseguridad para 2024 de los expertos en ciberseguridad de KnowBe4
Las tendencias previstas para 2024 incluyen la ciberdelincuencia relacionada con la IA y los métodos de defensa, los ataques de robo de datos interrumpirán los servicios de la cadena de suministro, las campañas de desinformación que darán lugar a esquemas de extorsión y más TAMPA BAY, FL, 4 de diciembre de 2023 /PRNewswire/ — KnowBe4,… Continue reading Las cinco mejores predicciones de ciberseguridad para 2024 de los expertos en ciberseguridad de KnowBe4
Pipplet lança Talent IA: Uma Mudança de Paradigma na Tecnologia de Avaliação Linguística
A nova ferramenta de avaliação de línguas emprega inteligência artificial para oferecer suporte a múltiplos idiomas, além de possuir medidas aprimoradas de segurança em testes online, atendendo à necessidade global por avaliações ágeis e confiáveis em grande escala. PARIS, 4 de dezembro de 2023 /PRNewswire/ — Pipplet, líder mundial em avaliação de idiomas e subsidiária… Continue reading Pipplet lança Talent IA: Uma Mudança de Paradigma na Tecnologia de Avaliação Linguística